REQUEST A DEMO
Total
USD $0.00
Search more companies

Magnapharm SK s. r. o. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Magnapharm SK s. r. o. Profile Updated: April 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

A&D Pharma is the leading pharmaceutical wholesale, sales and marketing services and retail business, founded in 1994 in Romania. A&D Pharma started its regional expansion in CEE countries, aquiring 5 companies in Poland, Czech Republic, Bulgaria and Slovakia in 2010. Company offers a full spectrum of marketing, promotion, regulatory, public affairs and selling services for a wide portfolio of medicine, medical devices, healthcare and OTC producers.

Headquarters
Digital Park III/E, Einsteinova 19
Bratislava; Bratislavsky; Postal Code: 85101

Contact Details: Purchase the Magnapharm SK s. r. o. report to view the information.

Website: http://www.adpharma.com

Basic Information
Total Employees:
Purchase the Magnapharm SK s. r. o. report to view the information.
Outstanding Shares:
Purchase the Magnapharm SK s. r. o. report to view the information.
Registered Capital:
Purchase the Magnapharm SK s. r. o. report to view the information.
Incorporation Date:
June 01, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Magnapharm SK s. r. o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
31.19%
Total operating revenue
27.61%
Operating profit (EBIT)
-71.02%
EBITDA
-70.88%
Net Profit (Loss) for the Period
-66.69%
Total assets
8.7%
Total equity
340.34%
Operating Profit Margin (ROS)
-19.62%
Net Profit Margin
-17.56%
Return on Equity (ROE)
178.32%
Debt to Equity Ratio
1.8%
Quick Ratio
1.38%
Cash Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?